Clinical Trial Update: Effects of Alogliptin on Pancreatic Beta Cell Function [NA]

View source ↗

Summary

An update on a clinical trial assessing alogliptin's effect on pancreatic beta cell function in type 2 diabetes; the current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Nesina (alogliptin)

Snippet

Sponsor: Aichi Gakuin University | Conditions: Diabetes Mellitus, Type 2 | NA | Status: UNKNOWN